Deulorlatinib
Deulorlatinib (compound A), a deuterated derivative of Lorlatinib (HY-12215), is a potent inhibitor of tyrosine kinase demonstrating the potential for the research of ALK-positive advanced NSCLC[1][2].
Product Specifications
CAS Number
[2131126-33-3]
UNSPSC
12352005
Target
Isotope-Labeled Compounds
Type
Isotope-Labeled Compounds
Related Pathways
Others
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
N#CC1=C2C3=CN=C(N)C(O[C@@H](C4=CC(F)=CC=C4C(N(CC2=NN1C([2H])([2H])[2H])C)=O)C)=C3
Molecular Formula
C21H16D3FN6O2
Molecular Weight
409.43
References & Citations
[1]Shenzhen TargetRx, Inc. Process for preparation of macrocycle. World Intellectual Property Organization, WO2017148325 A1 2017-09-08
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6220116-01 0.1 mL
CD45 (B220, CD45R, GP180, Leukocyte common antigen (LCA), Loc, Ly-5, Lyt-4, Protein tyrosine phosphatase receptor type C (PTPRC), Receptor-type tyrosine-protein phosphatase C, T200 glycoprotein) (BSA & Azide Free) (MaxLight 550)
Ask
View Details MBS6220116-02 5x 0.1 mL
CD45 (B220, CD45R, GP180, Leukocyte common antigen (LCA), Loc, Ly-5, Lyt-4, Protein tyrosine phosphatase receptor type C (PTPRC), Receptor-type tyrosine-protein phosphatase C, T200 glycoprotein) (BSA & Azide Free) (MaxLight 550)
Ask
View Details 